The notices it replaced
- Reissues: PAR-10-230 Innovative Therapies and Tools for Screenable Disorders in Newborns (R01)
- 2 steps back: PAR-07-184 Innovative Therapies and Clinical Studies for Screenable Disorders (R01)
- 3 steps back: PAR-06-060
Replaced by PAR-18-689.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,409,997 in first-year total cost, median $397,221.
Most frequent study sections
- Special Emphasis Panel[ZRG1 GGG-Q (50)]4
- Special Emphasis Panel[ZRG1 GGG-A (50)]2
- Special Emphasis Panel[ZRG1 GGG-B (50)]1
- Special Emphasis Panel[ZRG1 GGG-K (51)]1
Most frequent institutions
- BOSTON CHILDREN'S HOSPITAL2
- OREGON HEALTH & SCIENCE UNIVERSITY2
- RESEARCH INST OF FOX CHASE CAN CTR2
- MAYO CLINIC ROCHESTER1
- UNIVERSITY OF UTAH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Diet and the CPT1A arctic variant: Impact on the Health of Alaska Native Children1R01HD089951-01 | DILLARD, DENISE AKOELLER, DAVID M | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $437,407 | ZRG1 |
| 2017 | Towards Improved Therapy for Classic Galactosemia1R01HD089933-01A1 | LAI, KENT | UNIVERSITY OF UTAH, UT | $314,708 | ZRG1 |
| 2016 | Novel therapy for monoamine neurotransmitter deficiency in PKU2R01NS080866-05 | HARDING, CARY O. | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $397,279 | ZRG1 |
| 2016 | A New View of PAH Allostery - Correlation with Disease-Associated Alleles1R01NS100081-01A1 | JAFFE, EILEEN K | RESEARCH INST OF FOX CHASE CAN CTR, PA | $382,611 | ZRG1 |
| 2015 | Immunodeficient FAH-/- Pigs1R01DK106667-01 | NYBERG, SCOTT L | MAYO CLINIC ROCHESTER, MN | $402,019 | ZRG1 |
| 2014 | Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia1R01HD076258-01A1 · under PAR-10-230 | GRANT, PATRICIA ELLEN | BOSTON CHILDREN'S HOSPITAL, MA | $714,129 | ZRG1 |
| 2014 | Treatment of CBS Deficiency with Proteostasis Modulators1R01DK101404-01 · under PAR-10-230 | KRUGER, WARREN D | RESEARCH INST OF FOX CHASE CAN CTR, PA | $397,163 | ZRG1 |
| 2014 | Genetic screening and therapies for nemaline myopathies1R01HD075802-01A1 · under PAR-10-230 | BEGGS, ALAN H. | BOSTON CHILDREN'S HOSPITAL, MA | $364,681 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.